Table 1.
Study population (N = 406) |
|
---|---|
Men, % | 47.5 (193) |
Age, years | 48 (39; 58) |
Smoking, % | |
Never smoker | 41.4 (168) |
Ex-smoker | 34.2 (307) |
Current smoker | 24.4 (99) |
Alcohol consumption, g/d | 4.9 (1.5; 10.9) |
BMI, kg/m2 | 26.7 (24.1; 30.0) |
Lean body mass, kg | 53.3 (46.8; 65.4) |
Waist circumference, cm | 87 (79; 97) |
HbA1c, % | 5.1 (4.8; 5.5) |
Systolic BP, mmHg | 123.5 (112.0; 134.0) |
Diastolic BP, mmHg | 76.0 (70.0; 82.5) |
LVMI, g/m2.7 | 39.1 (31.5; 47.8) |
Fractional shortening, % | 42.0 (37.1; 47.5) |
History of myocardial infarction, % | 0 (0) |
History of stroke, % | 0.7 (3) |
History of heart failure, % | 2.0 (8) |
eGFR, ml/min/1.73m2 | 99.0 (89.7; 108.6) |
ASAT, µkatal/l | 0.30 (0.14) |
ALAT, µkatal/l | 0.43 (0.25) |
GGT, µkatal/l | 0.63 (0.55) |
Total cholesterol, mg/dla | 252 (219; 283) |
LDL cholesterol, mg/dla | 148 (126; 175) |
HDL cholesterol, mg/dla | 64 (56; 76) |
Triglycerides, mg/dla | 109 (74; 154) |
BMI Body mass index, BP Blood pressure, eGFR Estimated glomerular filtration rate, HbA1c Glycated hemoglobin, LVMI Left ventricular mass index, HDL High-density lipoprotein, LDL Low-density lipoprotein, ALAT Alanine aminotransferase, ASAT Aspartate aminotransferase, GGT Gamma-glutamyltransferase. Continuous data are expressed as median (Q1; Q3); Nominal data are given as percentages (N). aMeasured by NMR spectroscopy